The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global potassium citrate market was valued at US$ 692.6 Million in 2021.
We expect the global potassium citrate market to exhibit a CAGR of 4.10% during 2022-2027.
The widespread utilization of potassium citrate in the healthcare sector, as it aids in providing body
fluid volume, treating kidney stone conditions, reducing the risk of metabolic ailments, maintaining a
healthy heart, etc., is primarily driving the global potassium citrate market.
The sudden outbreak of the COVID-19 pandemic had led to the implementation of stringent
lockdown regulations across several nations, resulting in the temporary closure of numerous
manufacturing units for potassium citrate.
Based on the function, the global potassium citrate market has been segmented into acidulant,
emulsifier, stabilizer, antioxidants, and others. Among these, emulsifier represents the largest
Based on the end user, the global potassium citrate market can be bifurcated into food and
beverages, pharmaceuticals, personal care, and others. Currently, the food and beverage sector
accounts for the majority of the total market share.
On a regional level, the market has been classified into North America, Europe, Asia-Pacific, Middle
East and Africa, and Latin America, where Asia-Pacific currently dominates the global market.
Some of the major players in the global potassium citrate market include Archer-Daniels-Midland
Company, ATPGroup, Cargill Incorporated, Dr. Paul Lohmann GmbH & Co. KGaA, FBC Industries,
Foodchem International Corporation, Gadot Biochemical Industries Ltd., Huangshi Xinghua
Biochemical Co. Ltd., Jiangsu Mupro IFT Corp., Jungbunzlauer Suisse AG, Niran BioChemical Limited,
RZBC Group Co. Ltd., and Tate & Lyle PLC.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at